MedTech Dive - Latest News

J&J starts IVL trial in ‘difficult-to-cross’ coronary arteries

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.

Apr 8, 2025 - 14:59
 0
J&J starts IVL trial in ‘difficult-to-cross’ coronary arteries

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.

Read More

Tags:

Previous Article

Complex challenges: Coca-Cola’s plastic use continues to grow

Next Article

Blencowe signs offtake agreement

Related Posts

Hospital-at-home companies DispatchHealth, Medically Home to merge

Hospital-at-home companies DispatchHealth, Medically Ho...

Mar 21, 2025  0

J&J expects tariff charge of $400M this year

J&J expects tariff charge of $400M this year

Apr 16, 2025  0

VitalConnect raises $100M for heart monitor patch

VitalConnect raises $100M for heart monitor patch

Feb 21, 2025  0